ADC Therapeutics SA (ADCT)

ADC Therapeutics Revenue

ADC Therapeutics had revenue of $20.85M in the quarter ending March 31, 2026, a decrease of -9.47%. This brings the company's revenue in the last twelve months to $79.18M, up 4.43% year-over-year. In the year 2025, ADC Therapeutics had annual revenue of $81.36M with 14.85% growth.

• Revenue (ttm): $79.18M
• Revenue Growth: +4.43%
• P/S Ratio: 5.46
• Revenue / Employee: $410,233
• Employees: 193
• Market Cap: 432.45M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	81.36M	10.52M	14.85%
Dec 31, 2024	70.84M	1.28M	1.84%
Dec 31, 2023	69.56M	-140.35M	-66.86%
Dec 31, 2022	209.91M	175.99M	518.89%
Dec 31, 2021	33.92M	-	-

Data Source: S&P Global Market Intelligence Last updated: May 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error